Skip to content
No picture yet

Alunbrig 180 mg – DIN 02479222

Alunbrig is Brigatinib 180 mg (tablet), sold in Canada. It is used for lung cancer. It is supplied by Takeda Canada Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Brigatinib 180 mg

Brand
Alunbrig
Strength
180 mg
Used for
Lung cancer
Form
Tablet
Manufacturer
Takeda Canada Inc
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02479222

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Brigatinib pills and guides

What is Brigatinib used for?

Brigatinib is used for lung cancer.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

ALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.

From the FDA-approved label on DailyMed (published Jan 19, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02479222.
  • It names Alunbrig, Brigatinib 180 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Alunbrig by Takeda Canada Inc.

In Canada: prescription only.

Ingredients

Active: Brigatinib

Other Brigatinib pills